Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | L3MBTL1 | Q9Y468 | 2/20 | 0.42 |
| ▸ | PPARG | P37231 | 1/20 | 0.40 |
| ▸ | PPARA | Q07869 | 1/20 | 0.40 |
| ▸ | UTS2R | Q9UKP6 | 2/20 | 0.38 |
| ▸ | KMT2A | Q03164 | 3/20 | 0.36 |
| ▸ | TDP1 | Q9NUW8 | 2/20 | 0.36 |
| ▸ | ATM | Q13315 | 1/20 | 0.36 |
| ▸ | AOC3 | Q16853 | 1/20 | 0.34 |
| ▸ | KEAP1 | Q14145 | 1/20 | 0.34 |
| ▸ | NFE2L2 | Q16236 | 1/20 | 0.34 |
| ▸ | ELANE | P08246 | 1/20 | 0.34 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL2527548 | 0.91 | KMT2A (0.46) | L3MBTL1PPARGPPARAUTS2RKMT2A | |
| SCHEMBL2527448 | 0.91 | KMT2A (0.41) | L3MBTL1PPARGPPARAKMT2ATDP1 | |
| SCHEMBL2526376 | 0.90 | KMT2A (0.46) | L3MBTL1PPARGPPARAKMT2ATDP1 | |
| SCHEMBL2526417 | 0.90 | KMT2A (0.46) | L3MBTL1PPARGPPARAUTS2RKMT2A | |
| SCHEMBL2529210 | 0.90 | KMT2A (0.40) | L3MBTL1PPARGPPARAKMT2ATDP1 | |
| SCHEMBL2530995 | 0.90 | PPARG (0.39) | L3MBTL1PPARGPPARAKMT2ATDP1 | |
| SCHEMBL2529626 | 0.90 | KMT2A (0.40) | L3MBTL1PPARGPPARAKMT2ATDP1 | |
| SCHEMBL2525540 | 0.89 | PPARG (0.41) | L3MBTL1PPARGPPARAKMT2AAOC3 | |
| SCHEMBL2527784 | 0.89 | PPARG (0.43) | PPARGPPARAKMT2A | |
| SCHEMBL2525523 | 0.89 | PPARG (0.43) | PPARGPPARAKMT2AATM |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8039501-B2 | Synephrine derivatives useful as anti-inflammatory agents | UNIVERSITEIT GENT (BE) | 2011-10-18 | — | — | US | disclosed |
| US-20090029999-A1 | Synephrine derivatives useful as anti-inflammatory agents | UNIVERSITEIT GENT (BE) | 2009-01-29 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20090029999-A1 | Synephrine derivatives useful as anti-inflammatory agents | HRH1, HRH3, HRH2 | L3MBTL1 4486/4885PPARG 1096/4885PPARA 381/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.